PROPANC BIOPHARMA, INC. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
PROPANC BIOPHARMA, INC. (PPCB) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$93.35 thousand for the 3-month period ending 2026-03-31, per its S-1 filed 2026-07-17.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-07-17
- PROPANC BIOPHARMA, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was -$93.35K.
- PROPANC BIOPHARMA, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-12-31 was -$7.85K, a 102.44% decline year-over-year.
- PROPANC BIOPHARMA, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-09-30 was $17.04K.
- PROPANC BIOPHARMA, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-06-30 was -$145.64K.
- PROPANC BIOPHARMA, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was $60.33K, a 59.61% decline from fiscal 2022.
- PROPANC BIOPHARMA, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2022 was $149.34K.
- PROPANC BIOPHARMA, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2021 was -$182.47K, a 190.93% decline from fiscal 2020.
- PROPANC BIOPHARMA, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2020 was $200.67K, a 71.70% decline from fiscal 2019.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-03-31 | -$93.35K S-1 · filed 2026-07-17 | -$101.19K derived: sum of 2 quarters · filed 2026-07-17 | -$84.15K S-1 · filed 2026-07-17 | -$229.79K derived: sum of 4 quarters · filed 2026-07-17 |
| 2025-12-31 | -$7.85K S-1 · filed 2026-04-10 | $9.20K S-1 · filed 2026-04-10 | -$136.44K derived: sum of 3 quarters · filed 2026-07-17 | -$163.75K derived: sum of 4 quarters · filed 2026-07-17 |
| 2025-09-30 | $17.04K 10-Q · filed 2025-11-14 | -$128.60K derived: sum of 2 quarters · filed 2026-07-17 | -$155.91K derived: sum of 3 quarters · filed 2026-07-17 | $165.32K derived: sum of 4 quarters · filed 2026-07-17 |
| 2025-06-30 | -$145.64K derived: S-1 12 month − S-1 9 month · filed 2026-07-17 | -$172.95K derived: sum of 2 quarters · filed 2026-07-17 | $148.28K derived: sum of 3 quarters · filed 2026-07-17 | $49.34K S-1 · filed 2026-07-17 |
| 2025-03-31 | -$27.31K S-1 · filed 2026-07-17 | $293.92K derived: sum of 2 quarters · filed 2026-07-17 | $194.98K S-1 · filed 2026-07-17 | $125.11K derived: sum of 4 quarters · filed 2026-07-17 |
| 2024-12-31 | $321.23K S-1 · filed 2026-04-10 | $222.29K S-1 · filed 2026-04-10 | $152.42K derived: sum of 3 quarters · filed 2026-07-17 | $257.80K derived: sum of 4 quarters · filed 2026-07-17 |
| 2024-09-30 | -$98.94K 10-Q · filed 2025-11-14 | -$168.81K derived: sum of 2 quarters · filed 2026-07-17 | -$63.43K derived: sum of 3 quarters · filed 2026-07-17 | -$197.91K derived: sum of 4 quarters · filed 2026-07-17 |
| 2024-06-30 | -$69.87K derived: S-1 12 month − 10-Q 9 month · filed 2026-07-17 | $35.51K derived: sum of 2 quarters · filed 2026-07-17 | -$98.97K derived: sum of 3 quarters · filed 2026-07-17 | -$25.30K S-1 · filed 2026-07-17 |
| 2024-03-31 | $105.38K 10-Q · filed 2025-05-15 | -$29.10K derived: sum of 2 quarters · filed 2025-05-15 | $44.57K 10-Q · filed 2025-05-15 | $45.70K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | -$134.48K 10-Q · filed 2025-02-14 | -$60.81K 10-Q · filed 2025-02-14 | -$59.68K derived: sum of 3 quarters · filed 2025-02-14 | -$19.06K derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-09-30 | $73.67K 10-Q · filed 2024-11-14 | $74.80K derived: sum of 2 quarters · filed 2024-11-14 | $115.42K derived: sum of 3 quarters · filed 2024-11-14 | $7.61K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $1.13K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30 | $41.74K derived: sum of 2 quarters · filed 2024-09-30 | -$66.07K derived: sum of 3 quarters · filed 2024-09-30 | $60.33K 10-K · filed 2024-09-30 |
| 2023-03-31 | $40.61K 10-Q · filed 2024-05-15 | -$67.20K derived: sum of 2 quarters · filed 2024-05-15 | $59.20K 10-Q · filed 2024-05-15 | $207.14K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | -$107.81K 10-Q · filed 2024-02-20 | $18.58K 10-Q · filed 2024-02-20 | $166.53K derived: sum of 3 quarters · filed 2024-02-20 | $111.43K derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-09-30 | $126.40K 10-Q · filed 2023-11-14 | $274.34K derived: sum of 2 quarters · filed 2023-11-14 | $219.25K derived: sum of 3 quarters · filed 2023-11-14 | $211.55K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $147.94K derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-28 | $92.85K derived: sum of 2 quarters · filed 2023-09-28 | $85.15K derived: sum of 3 quarters · filed 2023-09-28 | $149.34K 10-K · filed 2023-09-28 |
| 2022-03-31 | -$55.10K 10-Q · filed 2023-05-15 | -$62.79K derived: sum of 2 quarters · filed 2023-05-15 | $1.40K 10-Q · filed 2023-05-15 | $32.73K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | -$7.70K 10-Q · filed 2023-02-10 | $56.50K 10-Q · filed 2023-02-10 | $87.83K derived: sum of 3 quarters · filed 2023-02-10 | $117.55K derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-09-30 | $64.19K 10-Q · filed 2022-11-14 | $95.52K derived: sum of 2 quarters · filed 2022-11-14 | $125.25K derived: sum of 3 quarters · filed 2022-11-14 | -$42.52K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $31.33K derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-28 | $61.05K derived: sum of 2 quarters · filed 2022-09-28 | -$106.71K derived: sum of 3 quarters · filed 2022-09-28 | -$182.47K 10-K · filed 2022-09-28 |
| 2021-03-31 | $29.72K 10-Q · filed 2022-05-16 | -$138.04K derived: sum of 2 quarters · filed 2022-05-16 | -$213.80K 10-Q · filed 2022-05-16 | -$2.23M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | -$167.76K 10-Q · filed 2022-02-14 | -$243.52K 10-Q · filed 2022-02-14 | -$2.26M derived: sum of 3 quarters · filed 2022-02-14 | $22.96K derived: sum of 4 quarters · filed 2022-02-14 |
| 2020-09-30 | -$75.75K 10-Q · filed 2021-11-12 | -$2.09M derived: sum of 2 quarters · filed 2021-11-12 | $190.72K derived: sum of 3 quarters · filed 2021-11-12 | -$438.77K derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | -$2.02M derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-28 | $266.48K derived: sum of 2 quarters · filed 2021-09-28 | -$363.01K derived: sum of 3 quarters · filed 2021-09-28 | $200.67K 10-K · filed 2021-09-28 |
| 2020-03-31 | $2.28M 10-Q · filed 2021-05-14 | $1.65M derived: sum of 2 quarters · filed 2021-05-14 | $2.22M 10-Q · filed 2021-05-14 | $2.41M derived: sum of 4 quarters · filed 2021-05-14 |
| 2019-12-31 | -$629.49K 10-Q · filed 2021-02-12 | -$65.81K 10-Q · filed 2021-02-12 | $124.33K derived: sum of 3 quarters · filed 2021-02-12 | $8.77K derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-09-30 | $563.69K 10-Q · filed 2020-11-16 | $753.83K derived: sum of 2 quarters · filed 2020-11-16 | $638.26K derived: sum of 3 quarters · filed 2020-11-16 | $996.54K derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-06-30 | $190.14K derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-01 | $74.57K derived: sum of 2 quarters · filed 2020-10-01 | $432.85K derived: sum of 3 quarters · filed 2020-10-01 | $709.07K 10-K · filed 2020-10-01 |
| 2019-03-31 | -$115.57K 10-Q · filed 2020-05-15 | $242.71K derived: sum of 2 quarters · filed 2020-05-15 | $518.93K 10-Q · filed 2020-05-15 | $990.24K derived: sum of 4 quarters · filed 2020-05-15 |
| 2018-12-31 | $358.28K 10-Q · filed 2020-02-14 | $634.50K 10-Q · filed 2020-02-14 | $1.11M derived: sum of 3 quarters · filed 2020-02-14 | $1.30M derived: sum of 4 quarters · filed 2020-02-14 |
| 2018-09-30 | $276.22K 10-Q · filed 2019-11-14 | $747.52K derived: sum of 2 quarters · filed 2019-11-14 | $946.16K derived: sum of 3 quarters · filed 2019-11-14 | $965.49K derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | $471.31K derived: 10-K 12 month − 10-Q 9 month · filed 2019-10-15 | $669.94K derived: sum of 2 quarters · filed 2019-10-15 | $689.27K derived: sum of 3 quarters · filed 2019-10-15 | $499.68K 10-K · filed 2019-10-15 |
| 2018-03-31 | $198.63K 10-Q · filed 2019-05-15 | $217.96K derived: sum of 2 quarters · filed 2019-05-15 | $28.37K 10-Q · filed 2019-05-15 | -$27.54K derived: sum of 4 quarters · filed 2019-05-15 |
| 2017-12-31 | $19.33K 10-Q · filed 2019-02-14 | -$170.26K 10-Q · filed 2019-02-14 | -$226.18K derived: sum of 3 quarters · filed 2019-02-14 | -$700.17K derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-09-30 | -$189.59K 10-Q · filed 2018-11-13 | -$245.51K derived: sum of 2 quarters · filed 2018-11-13 | -$719.50K derived: sum of 3 quarters · filed 2018-11-13 | -$237.79K derived: sum of 4 quarters · filed 2018-11-13 |
| 2017-06-30 | -$55.91K derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-17 | -$529.91K derived: sum of 2 quarters · filed 2018-09-17 | -$48.19K derived: sum of 3 quarters · filed 2018-09-17 | -$273.01K 10-K · filed 2018-09-17 |
| 2017-03-31 | -$474.00K 10-Q · filed 2018-05-10 | $7.72K derived: sum of 2 quarters · filed 2018-05-10 | -$217.10K 10-Q · filed 2018-05-10 | -$60.39K derived: sum of 4 quarters · filed 2018-05-10 |
| 2016-12-31 | $481.72K 10-Q · filed 2018-02-09 | $256.90K 10-Q · filed 2018-02-09 | $413.61K derived: sum of 3 quarters · filed 2018-02-09 | $175.31K derived: sum of 4 quarters · filed 2018-02-09 |
| 2016-09-30 | -$224.82K 10-Q · filed 2017-11-09 | -$68.11K derived: sum of 2 quarters · filed 2017-11-09 | -$306.40K derived: sum of 3 quarters · filed 2017-11-09 | -$452.95K derived: sum of 4 quarters · filed 2017-11-09 |
| 2016-06-30 | $156.71K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-28 | -$81.58K derived: sum of 2 quarters · filed 2017-09-28 | -$228.13K derived: sum of 3 quarters · filed 2017-09-28 | $30.30K 10-K · filed 2017-09-28 |
| 2016-03-31 | -$238.29K 10-Q · filed 2017-05-08 | -$384.84K derived: sum of 2 quarters · filed 2017-05-08 | -$126.41K 10-Q · filed 2017-05-08 | |
| 2015-12-31 | -$146.55K 10-Q · filed 2017-02-14 | $111.88K 10-Q · filed 2017-02-14 | ||
| 2015-09-30 | $258.43K 10-Q · filed 2016-11-10 | |||
| 2015-06-30 | $403.83K 10-K · filed 2016-09-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |